BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230530
DTEND;VALUE=DATE:20230602
DTSTAMP:20260516T060142
CREATED:20230222T124243Z
LAST-MODIFIED:20230222T124243Z
UID:36641-1685404800-1685663999@www.pharmajournalist.com
SUMMARY:5th Treg Summit
DESCRIPTION:With investment into the Treg field at an all time high\, excitement is overflowing at the prospect of these remarkable cells being game-changers in the long-term treatment of autoimmunity\, inflammation and transplantation. As this enthusiasm coincides with multiple clinical readouts and several more therapies entering the clinic\, it remains vital for Treg trailblazers to come together to recognize therapy efficacy\, determine safety and translate the next-generation of therapies into the clinic. \nThe Treg Summit returns for the 5th year to unite this dedicated community of industry and academic experts\, and remains the go-to industry forum to advance both cell and non-cell based approaches to unlock the potential of Tregs to treat indications with huge unmet clinical need. \nWith 3 jam-packed days of content across CAR-\, TCR– and polyclonal Tregs as well as IL-2\, muteins and small molecules\, you won’t want to miss this unrivalled opportunity to collaborate with your peers in the Treg field to explore clinical advances\, discuss challenges and discover next-gen methods to take Treg therapies to the next level. \nWhy Attend Now? \n\nOver $2 billion has been thrown into the Treg space in the past 8 months alone\, reflecting the potential of these therapies\n2022 saw the first-ever dosing of a human with a CAR-Treg cell therapy paving the way for the rest of the engineered Treg field\nVital clinical updates determine the safety and efficacy of Treg modulating therapies\n\nSecure your place today – https://ter.li/jddnbx
URL:https://www.pharmajournalist.com/event/5th-treg-summit/
LOCATION:Hyatt Regency Boston Downtown\, One Ave. de Lafayette\, Boston\, MA\, 02111\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230531
DTEND;VALUE=DATE:20230603
DTSTAMP:20260516T060142
CREATED:20230208T093703Z
LAST-MODIFIED:20230208T093703Z
UID:36555-1685491200-1685750399@www.pharmajournalist.com
SUMMARY:2nd Cell Therapy Potency Assay Summit
DESCRIPTION:The 2nd Cell Therapy Potency Assay will gather 100+ experts working to rationally design better potency assays to smooth the path to regulatory approval and minimize hold times with scientifically rigorous and informative potency measurements. \nWhether you are submitting your first IND or gearing up towards BLA submission\, this critical meeting of minds is your premier opportunity to join the likes of bluebird bio\, Arsenal Bio\, Takeda\, Merck\, Sana Biotechnology and more\, to gain critical updates on regulatory interactions and unpick how industry peers are approaching potency assay development. \nLeave this meeting equipped with industry insights to understand what potency assays are showing\, develop practical\, compatible\, reproducible assays; and better characterize your cell therapy products for targeted\, untargeted\, allogeneic and autologous platforms in oncology and non-oncology indications. \nTo know more visit: https://ter.li/zc871s
URL:https://www.pharmajournalist.com/event/2nd-cell-therapy-potency-assay-summit/
LOCATION:Hilton Boston Back Bay\, 40 Dalton St\, Boston\, MA\, 02115\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230531
DTEND;VALUE=DATE:20230603
DTSTAMP:20260516T060142
CREATED:20230307T092630Z
LAST-MODIFIED:20230307T092630Z
UID:36769-1685491200-1685750399@www.pharmajournalist.com
SUMMARY:5th Age-Related Disease Therapeutics Summit
DESCRIPTION:Whether it’s in cardiovascular disease\, Alzheimer’s or osteoarthritis\, therapeutic innovations to target the mechanisms of aging are making significant headway to clinical trials. With increased investments and recognition\, along with the escalation of the burden of age-related disease\, research and development to meet this unmet medical need has never been more important. \nThe 5th Age-Related Disease Therapeutics Summit is the only industry-focused meeting dedicated to uniting 100+ biopharma drug developers\, pioneering academics\, and prominent investors striving to develop effective\, novel drugs that promote healthy aging and overcome major translational and regulatory obstacles. \nJam-packed with the most cutting-edge insights and opportunities to reunite with and hear from your peers on the next steps forward in developing the safest and most efficacious drug to promote a healthier and enhanced quality of life. \nTo know more visit: https://ter.li/sl5og6
URL:https://www.pharmajournalist.com/event/5th-age-related-disease-therapeutics-summit/
LOCATION:Marines Memorial Club and Hotel\, 609 Sutter St\, San Francisco\, CA\, 94102\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR